The HinduLean L·
Natco Pharma Q1 net, revenue slump on lower cancer drug sales
Decline largely attributable to Lenalidomide revenue, generic drugmaker said as its shares tumbled more than 5%
Read at The Hindu →
Business · 1 sources covering this
Natco Pharma Q1 net, revenue slump on lower cancer drug sales
Decline largely attributable to Lenalidomide revenue, generic drugmaker said as its shares tumbled more than 5%
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/fa96a7ef55bd804c779c7f90e18ec67c7c74f4cf" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Natco Pharma Q1 net, revenue slump on lower cancer drug sales"></iframe>
